|
Central & Eastern Europe Patent Law News is an EIN News Service for patents and trademarks professionals. Constantly updated news and information about Central & Eastern Europe Patents & Trademarks.
Latest Central & Eastern Europe Patent Law News
- Energy's 'face of the future' 7 Nov 2009 11:10 GMT
... at the University of Alberta, then a law degree from Columbia University in New York. ... public sector can initiate research that will attract private sector investment and development to take ... do it? They start with a proprietary, patented technology that can turn nearly any kind ...
- BUYINS.NET: CGV, RPRX, CWCO, NEXM, KDE, CNTY Expected To Be Lower Leading Up To Next Earnings Releases 6 Nov 2009 10:44 GMT
... indicator that predicts how a stock will act before its earnings are released. The specific technology ... and function. In addition, it holds a patent portfolio of phentolamine-based product candidates, including VASOMAX ... holds a 33.3% ownership interest in Casinos Poland Ltd, which owns and operates seven full ...
- SMARTRAC Selected as Inlay Supplier for Ticketing Projects in Seville and Riga 6 Nov 2009 11:58 GMT
... inlays which are manufactured with our superior patented ChipLink technology", says Manfred Rietzler, Chief Technology ... mass transportation offer numerous benefits over conventional contact-based tickets. As the ticket validation is carried ... trading as a stock corporation under Dutch law with its registered headquarters in Amsterdam. The ...
- Beckman Coulter Announces Third Quarter 2009 Results 2 Nov 2009 17:35 GMT
... in constant currency) Revenue(2) 11.6% 3.8% ODS impact 8.8% 2.9% Recurring Revenue(2) 17.3% 10.0% ODS ... update these disclosures except as required by law. Change in Accounting for Convertible Debt Securities ... sublicense rights to obtain rights under certain patents to be used to develop a molecular ...
- Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA'˘ in Systemic Lupus Erythematosus 2 Nov 2009 05:31 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomized and treated 819 patients at ... meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences' ...
- Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Syst 2 Nov 2009 05:31 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomized and treated 819 patients at ... meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences' ...
- Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of belimumab in Systemic Lupus Erythematosus 2 Nov 2009 05:52 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomized and treated 819 patients at ... meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences’ ...
- Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of BENLYSTA in Systemic Lupus Erythematosus 2 Nov 2009 12:34 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomized and treated 819 patients at ... meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences' ...
- Human Genome Sciences and GlaxoSmithKline Announce Positive... 2 Nov 2009 13:56 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomized and treated 819 patients at ... meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences’ ...
- GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus 2 Nov 2009 14:24 GMT
... countries, primarily in Asia, South America and Eastern Europe. BLISS-76 randomised and treated 819 patients at ... of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements ... with facilities, intense competition, the uncertainty of patent and intellectual property protection, Human Genome Sciences’ ...
- The Estonian Patent Act 4 Nov 2009 07:57 GMT
... Your preferred homepage is already pre-selected according to the ... not use electronic or other means to extract details or information about Mondaq.com’s content, users ... addresses) to reputable contributing firms such as law firms who author those pages. We do ...
- Teva Reports Third Quarter 2009 Results 3 Nov 2009 07:00 GMT
... Teva's President and Chief Executive Officer. "In fact, for the first time, we crossed the billion ... Teva's geographies, particularly in the U.S., Russia, Poland, Germany, and Croatia. Exchange rate differences negatively ... applications, 136 were "Paragraph IV" applications challenging patents of branded products. Teva believes it is ...
- Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides Pipeline Update (BIZ) 5 Nov 2009 12:48 GMT
... and published on the following studies: -- Abstract P-9148 "Phase 1 study of the toll-like receptor ... Idera's intellectual property portfolio contains over 500 patents and patent applications worldwide. This portfolio holds ... were granted to the Company in Guatemala, Latvia, Macedonia, Morocco, New Zealand, and Singapore. The ...
- www.standoutstocks.com: Stocks That Stand Out For Nov. 2nd, 2009 Are BHWX, XDSL, BEHL, CBAI 2 Nov 2009 19:37 GMT
... Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release ... such forward-looking statements. mPhase Technologies Granted U.S. Patent for Safer Disposal of Smart NanoBattery LITTLE ... Research and Development arm located in Prague, Czech Republic and the Georgetown, South Carolina location ...
- Stocks That Stand Out For Nov. 2nd, 2009 Are BHWX, XDSL, BEHL, CBAI 2 Nov 2009 20:32 GMT
... Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release ... such forward-looking statements. mPhase Technologies Granted U.S. Patent for Safer Disposal of Smart NanoBattery LITTLE ... Research and Development arm located in Prague, Czech Republic and the Georgetown, South Carolina location ...
Powered by 
Central & Eastern Europe Patents News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Patents & Trademarks Today
|
a digital news provider
unwiredview.com:
courthousenews.com:
examiner.com:
thanhniennews.com:
guardian.co.uk:
macworld.co.uk: